RKV
$0.455
-1.087%
Rakovina Therapeutics Inc.News & Events
Last updated: Sep 3, 2025, 7:40 PM ET
Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update
GlobeNewswire AUG 28, 2025 6:12 PM EDTVANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (ȁ...READ ARTICLERakovina Therapeutics CSO Dr. Mads Daugaard Invited to Present at the 13th Tuscany Retreat on Cancer Research and Apoptosis
GlobeNewswire AUG 26, 2025 4:00 AM EDTVANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (ȁ...READ ARTICLERakovina Therapeutics and NanoPalm Ltd. Sign Letter of Intent to Form Joint Venture Leveraging AI-Discovered Oncology Therapies and Novel Lipid Nanoparticle Delivery Technologies
GlobeNewswire AUG 12, 2025 4:00 AM EDTVANCOUVER, British Columbia and RIYADH, Saudi Arabia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rakovina ...READ ARTICLERakovina Therapeutics Highlights Long-Standing Collaboration with the University of British Columbia and the Vancouver Prostate Centre
GlobeNewswire JUL 30, 2025 4:00 AM EDTVANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (ȁ...READ ARTICLERakovina Therapeutics Announces Stock Option Grants
GlobeNewswire JUL 29, 2025 5:00 PM EDTVANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: ...READ ARTICLERakovina Therapeutics Announces Warrant Exercise Incentive Program
GlobeNewswire JUL 24, 2025 5:00 PM EDTVANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: ...READ ARTICLERakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening
GlobeNewswire JUL 23, 2025 4:00 AM EDTVANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (ȁ...READ ARTICLERakovina Therapeutics Granted DTC Eligibility to Expand U.S. Investor Access
GlobeNewswire JUL 15, 2025 4:00 AM EDTVANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (ȁ...READ ARTICLERakovina Therapeutics Congratulates Partner - Variational AI for Winning LifeSciencesBC's 2025 Emerging Biotech Company of the Year Award
GlobeNewswire JUL 11, 2025 9:56 AM EDTVANCOUVER, British Columbia, July 11, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (...READ ARTICLERakovina Therapeutics Highlights Strength of Scientific Advisory Board Driving Innovation in AI-Enabled Oncology Drug Development
GlobeNewswire JUL 10, 2025 4:00 AM EDTVANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (ȁ...READ ARTICLE